GHK-CU
50 mgThe Element ResearchCOAs available · Purity > 98%
Limited stock
44.99 €View details →
Lyophilized research compound
GLP-3 20mg pour recherche
In-vitro research reagent. Not for human or veterinary consumption.
Protect your delivery
Optional at checkout: stuck, damaged or lost parcel — priority reshipment or refund.
Third-party testing · COAs availableTracked EU shippingCard or bank transfer
Ce produit est destiné exclusivement à la recherche scientifique in vitro et préclinique. Il n'est pas approuvé pour un usage humain ou vétérinaire.
How to reconstitute this vial?
20 mg vial — 4 essential steps, about 3 minutes.
- 1Gather: bacteriostatic water (BAC), 1 mL syringe, alcohol swab for the stopper.
- 2Draw the water volume from the calculator, then inject slowly along the inside wall of the vial.
- 3Never shake: roll the vial between your palms until fully dissolved (1–2 min).
- 4Store in the fridge (2–8 °C) and use within 28 days.
Vial format
5 mgout of stock
Bacteriostatic water
Reconstitution solvent · 10 ml
+15 €
1
Total
135 €
Limited stock on GLP-3 RTA 20MG, GHK 50MG, and MT2 10MG: for this SKU, availability may change quickly.
Shipping within 24–48h subject to availability.
COAs availablePurity > 98%Shipping 24–48hProtective packagingCard & bank transfer
Certificates of analysis
Documented batches for this product — PDF and third-party lab verification.
Batch GLP3-260707-01-10 · 99.796 %
10mg · 23 Jul 2026
This lyophilized peptide is intended for in-vitro and preclinical research. It is formulated to provide stability and purity suited to advanced research protocols. Not for direct human or veterinary consumption.
The Element Research peptides are selected for their long-term stability and compatibility with demanding research protocols. Lyophilization ensures optimal storage before reconstitution.
Mechanism of action
Triple action synergy
GLP-3 RTA 20MG is the first molecule to activate 3 hormonal receptors simultaneously, whereas semaglutide activates only one.
GLP-101Appetite control
Slows gastric emptying, increases satiety and reduces food intake. Acts on brain hunger receptors (hypothalamus).
GLP-1R receptor
GIP02Insulin sensitivity
Optimizes post-prandial insulin response and promotes controlled lipid storage, complementing the GLP-1 axis on glycemia.
GIPR receptor
Glucagon03Energy expenditure
Stimulates hepatic lipolysis and thermogenesis. Increases resting energy expenditure, the key differentiator vs other GLP-1s.
GCGR receptor
GLP-3 RTA 20MG activates all 3 simultaneously. Semaglutide (Ozempic) only activates GLP-1. Tirzepatide (Mounjaro) activates GLP-1 + GIP. GLP-3 RTA 20MG is the only one to also activate the Glucagon receptor, the source of its superiority in energy expenditure.
Related products
Complete your research protocol with these compounds.
